You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 65 No. 2, August 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CARCINOMA OF THE PANCREAS

Symptoms, Signs, and Results of Treatment in One Hundred Twenty-Two Cases

EUGENE E. CLIFFTON, M.D.

AMA Arch Surg. 1952;65(2):290-306.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DEFINITIVE surgical resection of carcinoma of the head of the pancreas or papilla of Vater is relatively recent1 and has been performed so infrequently that the proper evaluation of its place in treatment is difficult. The over-all results of treatment of carcinoma of the pancreas are even more difficult to establish, since most reported series include only cases with resection. Recent reviews by Loggan and Kleinsasser2 and Child3 make redundant a further complete review of the literature.

The incidence of carcinoma of the pancreas is not rare, as established from the 1949 figures of the Connecticut State Tumor Registry.4 It occurred 104 times in 4,661 registered cases, an incidence of 2.2%. The incidence in males was higher, 2.8%, as compared with 1.7% in women. This male-female ratio of 1.6: 1 compares with the 2: 1 and the 2.5: 1 ratio in postmortem series.5 All patients . . . [Full Text PDF of this Article]


Author Affiliations

NEW HAVEN, CONN.

From the Tumor Registry of the Section of Oncology of the Department of Surgery, Yale University School of Medicine.; Dr. Cliffton is Assistant Professor of Surgery (Oncology) Yale University School of Medicine.


Footnotes

This study was supported in part by the Jane Coffin Childs Fund 23-2, the Connecticut Cancer Society #222, the Damon Runyon Memorial Fund for Cancer Research #86, the Institutional Research Grant #47 of the American Cancer Society, and special funds of the Section of Oncology of Yale University School of Medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.